Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: Matched case-control study

Breast

Volumn 19, Issue 3, 2010, Pages 231-237

  Yu, Jeong Il ^a   Choi, Doo Ho ^a   Park, Won ^a   Huh, Seung Jae ^a   Cho, Eun Yoon ^a   Lim, Young Hyuk ^a   Ahn, Jin Suk ^a   Yang, Jung Hyun ^a   Nam, Suk Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Case control study; Invasive micropapillary carcinoma; Patterns of failure

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; ELECTRON THERAPY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PHOTON THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOUTH KOREA; TREATMENT FAILURE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; COHORT ANALYSIS; FEMALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 77953358635     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.01.020     Document Type: Article

References (26)

1. Siriaunkgul S., Tavassoli F.A. Invasive micropapillary carcinoma of the breast. Mod Pathol 1993, 6:660-662.
2. Acs G., Paragh G., Chuang S.T., Laronga C., Zhang P.J. The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma. Am J Surg Pathol 2009, 33:202-210.
3. Lui P.C., Lau P.P., Tse G.M., Tan P.H., Lo R.C., Tang V.W., et al. Fine needle aspiration cytology of invasive micropapillary carcinoma of the breast. Pathology 2007, 39:401-405.
4. Pettinato G., Manivel C.J., Panico L., Sparano L., Petrella G. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol 2004, 121:857-866.
5. Fu L., Ikuo M., Fu X.Y., Liu T.H., Shinichi T. [Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast]. Zhonghua Bing Li Xue Za Zhi 2004, 33:21-25.
6. Chen L., Fan Y., Lang R.G., Guo X.J., Sun Y.L., Cui L.F., et al. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol 2008, 16:155-163.
7. De la Cruz C., Moriya T., Endoh M., Watanabe M., Takeyama J., Yang M., et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int 2004, 54:90-96.
8. Kuroda H., Sakamoto G., Ohnisi K., Itoyama S. Clinical and pathologic features of invasive micropapillary carcinoma. Breast Cancer 2004, 11:169-174.
9. Luna-More S., de los Santos F., Breton J.J., Canadas M.A. Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. Pathol Res Pract 1996, 192:27-32.
10. Grimes D.A., Schulz K.F. Compared to what? Finding controls for case-control studies. Lancet 2005, 365:1429-1433.
11. Paterakos M., Watkin W.G., Edgerton S.M., Moore D.H., Thor A.D. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol 1999, 30:1459-1463.
12. Walsh M.M., Bleiweiss I.J. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 2001, 32:583-589.
13. Alvarado-Cabrero I., Alderete-Vazquez G., Quintal-Ramirez M., Patino M., Ruiz E. Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings. Ann Diagn Pathol 2009, 13:151-157.
14. Marchio C., Iravani M., Natrajan R., Lambros M.B., Savage K., Tamber N., et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol 2008, 215:398-410.
15. Nielsen H.M., Overgaard M., Grau C., Jensen A.R., Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006, 24:2268-2275.
16. Rugo H.S. The importance of distant metastases in hormone-sensitive breast cancer. Breast 2008, 17(Suppl. 1):S3-S8.
17. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002, 347:567-575.
18. Johansen H., Kaae S., Jensen M.B., Mouridsen H.T. Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study. Acta Oncol 2008, 47:633-638.
19. Tominaga T., Takashima S., Danno M. Randomized clinical trial comparing level II and level III axillary node dissection in addition to mastectomy for breast cancer. Br J Surg 2004, 91:38-43.
20. Liu M., Ju X., Willmarth N.E., Casimiro M.C., Ojeifo J., Sakamaki T., et al. Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. Am J Pathol 2009, 174:1910-1920.
21. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
22. Overgaard M., Hansen P.S., Overgaard J., Rose C., Andersson M., Bach F., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997, 337:949-955.
23. Nielsen H.M., Overgaard J., Grau C., Christensen J.J., Overgaard M. Audit of the radiotherapy in the DBCG 82 b&c trials - a validation study of the 1,538 patients randomised to postmastectomy radiotherapy. Radiother Oncol 2005, 76:285-292.
24. Louis-Sylvestre C., Clough K., Asselain B., Vilcoq J.R., Salmon R.J., Campana F., et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004, 22:97-101.
25. Rudenstam C.M., Zahrieh D., Forbes J.F., Crivellari D., Holmberg S.B., Rey P., et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 2006, 24:337-344.
26. NCCN clinical practice guidelines in oncology 2009; V1.